EUVIMEDOpdag EUVIMED
Video/Audio

Radiochemical Synthesis of 18F-Meta-Fluorobenzylguanidine (18F-mFBG) for PET/CT Imaging in Patients with Pheochromocytoma

Ying Han, Qianhe Xu, Guolin Wang, Shuyi Zhang, Pingping Zhou, Xili Lu, Xinhui Su, Zhenfeng Liu

Journal of Visualized Experiments · 2026-10-30 · (236)

DOI: 10.3791/71703 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, published online on 2026-10-30. Written by Ying Han and 7 co-authors. Institution: Department of Nursing, The First Affiliated Hospital, Zhejiang University School of Medicine. Major MEDLINE topics: Pheochromocytoma, Positron Emission Tomography Computed Tomography, Adrenal Gland Neoplasms, Radiopharmaceuticals.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Pheochromocytoma (PCC) is a relatively rare neuroendocrine tumor. Due to its diverse and often nonspecific clinical manifestations, PCC is frequently missed or misdiagnosed in clinical practice. As a positron-emitting tracer, 18F-meta-fluorobenzylguanidine (18F-mFBG) specifically targets and binds to the human norepinephrine transporter (hNET), and is used for disease diagnosis, lesion localization and assessment, and treatment planning. This study provides a detailed description of the entire process for 18F-mFBG, including radiolabeling, quality control, patient preparation, and positron emission tomography-computed tomography (PET/CT) imaging. The radiolabeling of 18F-mFBG was performed using a fully automated labeling module. Patient preparation followed a standardized protocol, which included patient instructions, explanation of the protocol, and intravenous administration of the radiopharmaceutical. The PET/CT imaging section details the acquisition and reconstruction parameter settings. Validated through 32 cases, the study demonstrated that key metrics such as maximum standardized uptake value (SUVmax) and target-to-background ratio (TBR) effectively distinguished PCC lesions and their uptake characteristics. The results indicate that 18F-mFBG PET/CT imaging is a non-invasive and rapid method that provides information on tumor burden in PCC, offering a basis for auxiliary diagnosis and treatment planning.

Subjects

MeSH terms (MEDLINE)

PheochromocytomaPositron Emission Tomography Computed TomographyAdrenal Gland NeoplasmsRadiopharmaceuticalsFluorine RadioisotopesGuanidinesHumans

Substances

RadiopharmaceuticalsFluorine RadioisotopesGuanidines

Authors and institutions

  • Department of Nursing, The First Affiliated Hospital, Zhejiang University School of Medicine.
  • Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine.
  • Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine; suxinhui@zju.edu.cn.
  • Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine; zhenfeng19792003@zju.edu.cn.

Cite

APA

Han, Y., Xu, Q., Wang, G., Zhang, S., Zhou, P., Lu, X., Su, X., & Liu, Z. (2026). Radiochemical Synthesis of 18F-Meta-Fluorobenzylguanidine (18F-mFBG) for PET/CT Imaging in Patients with Pheochromocytoma. Journal of Visualized Experiments. https://doi.org/10.3791/71703

Vancouver

Han Y, Xu Q, Wang G, Zhang S, Zhou P, Lu X, et al. Radiochemical Synthesis of 18F-Meta-Fluorobenzylguanidine (18F-mFBG) for PET/CT Imaging in Patients with Pheochromocytoma. Journal of Visualized Experiments. 2026. doi:10.3791/71703

BibTeX
@article{Han2026,
  author = {Han, Ying and Xu, Qianhe and Wang, Guolin and Zhang, Shuyi and Zhou, Pingping and Lu, Xili and Su, Xinhui and Liu, Zhenfeng},
  title = {Radiochemical Synthesis of 18F-Meta-Fluorobenzylguanidine (18F-mFBG) for PET/CT Imaging in Patients with Pheochromocytoma},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {236},
  doi = {10.3791/71703}
}
Start for free →